SecSonar.com

Century Therapeutics, Inc. (IPSC)

Century Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Century Therapeutics, Inc. (IPSC) is a Biotechnology company based in US with a market capitalization of $205.2M. Revenue grew 1556.8% year-over-year and free cash flow was negative at -$104.7M. This page tracks IPSC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 140 employees · IPO Jun 18, 2021

Valuation

Valuation & price

$2.34 · as of May 17, 2026 · -20.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.29

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.77$1.62$0.47Jul 25Dec 25Jul 26Jul 7, 25$0.55Jul 9, 25$0.63Jul 11, 25$0.60Jul 15, 25$0.58Jul 17, 25$0.58Jul 21, 25$0.57Jul 23, 25$0.64Jul 25, 25$0.63Jul 29, 25$0.58Jul 31, 25$0.55Aug 4, 25$0.56Aug 6, 25$0.54Aug 11, 25$0.49Aug 13, 25$0.53Aug 15, 25$0.56Aug 19, 25$0.55Aug 21, 25$0.54Aug 25, 25$0.51Aug 27, 25$0.52Aug 29, 25$0.49Sep 3, 25$0.47Sep 5, 25$0.50Sep 9, 25$0.50Sep 11, 25$0.52Sep 16, 25$0.49Sep 18, 25$0.51Sep 22, 25$0.48Sep 24, 25$0.48Sep 26, 25$0.51Sep 30, 25$0.50Oct 2, 25$0.50Oct 6, 25$0.56Oct 8, 25$0.58Oct 10, 25$0.57Oct 14, 25$0.56Oct 16, 25$0.56Oct 21, 25$0.56Oct 23, 25$0.59Oct 27, 25$0.60Oct 29, 25$0.58Oct 31, 25$0.58Nov 4, 25$0.57Nov 6, 25$0.54Nov 10, 25$0.55Nov 12, 25$0.56Nov 14, 25$0.47Nov 18, 25$0.49Nov 20, 25$0.49Nov 25, 25$0.53Nov 28, 25$0.55Dec 2, 25$0.53Dec 4, 25$0.53Dec 8, 25$0.57Dec 10, 25$0.59Dec 12, 25$0.56Dec 16, 25$0.62Dec 18, 25$0.76Dec 22, 25$0.86Dec 24, 25$1.04Dec 29, 25$1.00Jan 2, 26$0.99Jan 6, 26$0.90Jan 8, 26$1.77Jan 12, 26$2.04Jan 14, 26$2.02Jan 16, 26$2.17Jan 21, 26$2.04Jan 23, 26$2.42Jan 27, 26$2.65Jan 29, 26$2.01Feb 2, 26$1.84Feb 4, 26$1.79Feb 9, 26$1.95Feb 11, 26$1.79Feb 13, 26$1.75Feb 18, 26$2.10Feb 20, 26$2.06Feb 24, 26$2.13Feb 26, 26$2.24Mar 2, 26$2.26Mar 4, 26$2.43Mar 6, 26$2.56Mar 10, 26$2.77Mar 12, 26$2.50Mar 17, 26$2.29Mar 19, 26$2.49Mar 23, 26$2.37Mar 25, 26$2.07Mar 27, 26$2.02Mar 31, 26$2.26Apr 2, 26$2.13Apr 7, 26$2.26Apr 9, 26$2.26Apr 13, 26$2.27Apr 15, 26$2.59Apr 17, 26$2.60Apr 22, 26$2.44Apr 24, 26$2.22Apr 28, 26$2.20Apr 30, 26$2.29May 4, 26$2.29May 6, 26$2.34May 8, 26$2.29May 12, 26$2.29May 14, 26$2.38May 18, 26$2.28May 20, 26$2.25May 22, 26$2.26May 28, 26$2.38Jun 1, 26$2.36Jun 3, 26$2.07Jun 5, 26$2.13Jun 9, 26$2.21Jun 11, 26$2.24Jun 15, 26$2.30Jun 17, 26$2.25Jun 22, 26$2.30Jun 24, 26$2.29Jun 26, 26$2.32Jul 2, 26$2.43
$0.4652-week range$2.94
Loading valuation history…

Fundamentals

Key fundamentals

$205.2M

Market cap

1556.8%

Revenue growth (YoY)

88.0%

Gross margin

-$104.7M

Free cash flow (USD)

-$73.5M

Net debt

Net cash position

10.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$5.2MFY 2023$2.2MFY 2024$6.6MFY 2025$109.2M
$0$109.2M

Free cash flow by year

2019 → 2025

FY 2019$-18.6MFY 2020$-51.1MFY 2021$-134.0MFY 2022$-16.6MFY 2023$-102.1MFY 2024$-110.3MFY 2025$-104.7M
-$18.6M-$104.7M

Gross margin by year

2022 → 2025

FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 202588.0%
100.0%88.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

5

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEmployment Agreement AmendedJun 16, 2026Filing
  • Insider sellInsider Sell $4KCarr Douglas · SVP Finance & Operations · $3.7KJun 15, 2026Filing
  • Insider sellInsider Sell $6KRussotti Gregory · See Remarks · $5.8KJun 15, 2026Filing
  • 8-K eventAuthorized Shares AmendmentJun 12, 2026Filing
  • Insider sellInsider Sell $526Carr Douglas · SVP Finance & Operations · $525.6Jun 9, 2026Filing
  • Insider sellInsider Sell $1KRussotti Gregory · See Remarks · $1.1KJun 9, 2026Filing
  • 8-K eventPreclinical Research PresentationJun 8, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Insider sellInsider Sell $618Carr Douglas · SVP Finance & Operations · $618May 6, 2026Filing

Questions

Frequently asked questions

What is Century Therapeutics, Inc.'s market cap?

Century Therapeutics, Inc. (IPSC) has a market capitalization of $205.2M.

What is IPSC's P/E ratio?

A meaningful P/E ratio is not available for IPSC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IPSC's price-to-book (P/B) ratio?

IPSC trades at 1.29 times book value per share.

Are insiders buying IPSC stock?

SEC Form 4 filings show no open-market insider buys at Century Therapeutics, Inc. in the last 90 days (5 sells).

Same arena

Related companies in Biotechnology

CHRS

Coherus Oncology, Inc.

$198.7M

TNXP

Tonix Pharmaceuticals Holding Corp.

$198M

RNAC

Cartesian Therapeutics, Inc.

$212.4M

NBP

NovaBridge Biosciences

$213.2M

ARTV

Artiva Biotherapeutics, Inc.

$193.8M

PRLD

Prelude Therapeutics Incorporated

$218.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.